Covid-19: variants and vaccination
- PMID: 33757984
- DOI: 10.1136/bmj.n771
Covid-19: variants and vaccination
Conflict of interest statement
Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: none. The BMJ policy on financial interests is here: https://www.bmj.com/sites/default/files/attachments/resources/2016/03/16-current-bmj-education-coi-form.pdf."
Comment on
-
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study.BMJ. 2021 Mar 9;372:n579. doi: 10.1136/bmj.n579. BMJ. 2021. PMID: 33687922 Free PMC article.
Similar articles
-
Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study.PLoS Med. 2023 Jul 24;20(7):e1004274. doi: 10.1371/journal.pmed.1004274. eCollection 2023 Jul. PLoS Med. 2023. PMID: 37486927 Free PMC article.
-
Study protocol for COVID-19 breakthrough infections and vaccine-induced immune response among a cohort of healthcare workers, Bangladesh.PLoS One. 2024 Dec 31;19(12):e0316121. doi: 10.1371/journal.pone.0316121. eCollection 2024. PLoS One. 2024. PMID: 39739828 Free PMC article.
-
Clinical and immunological benefits of full primary COVID-19 vaccination in individuals with SARS-CoV-2 breakthrough infections: A prospective cohort study in non-hospitalized adults.J Clin Virol. 2024 Feb;170:105622. doi: 10.1016/j.jcv.2023.105622. Epub 2023 Nov 28. J Clin Virol. 2024. PMID: 38091664
-
Challenges of vaccination and herd immunity in COVID-19 and management strategies.Clin Respir J. 2022 Nov;16(11):708-716. doi: 10.1111/crj.13543. Epub 2022 Sep 29. Clin Respir J. 2022. PMID: 36172975 Free PMC article. Review.
-
Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barré syndrome?Eur J Med Res. 2023 Feb 25;28(1):98. doi: 10.1186/s40001-023-01055-0. Eur J Med Res. 2023. PMID: 36841799 Free PMC article. Review.
Cited by
-
Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication.bioRxiv [Preprint]. 2022 Mar 7:2022.03.06.483172. doi: 10.1101/2022.03.06.483172. bioRxiv. 2022. Update in: Life Sci Alliance. 2022 Oct 14;6(1):e202201449. doi: 10.26508/lsa.202201449. PMID: 35291294 Free PMC article. Updated. Preprint.
-
Effectiveness of Pulmonary Rehabilitation in Severe and Critically Ill COVID-19 Patients: A Controlled Study.Int J Environ Res Public Health. 2021 Aug 25;18(17):8956. doi: 10.3390/ijerph18178956. Int J Environ Res Public Health. 2021. PMID: 34501549 Free PMC article.
-
Eight Good Reasons for Careful Monitoring and Evaluation of the Vaccine Campaign against COVID-19: Lessons Learned through the Lombardy Experience for Dealing with Next Challenges.Int J Environ Res Public Health. 2022 Jan 19;19(3):1073. doi: 10.3390/ijerph19031073. Int J Environ Res Public Health. 2022. PMID: 35162097 Free PMC article. Review.
-
Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review.Int J Mol Sci. 2021 Apr 26;22(9):4526. doi: 10.3390/ijms22094526. Int J Mol Sci. 2021. PMID: 33926110 Free PMC article. Review.
-
Investigating the effect of vaccinated population on the COVID-19 prediction using FA and ABC-based feed-forward neural networks.Heliyon. 2023 Feb 11;9(2):e13672. doi: 10.1016/j.heliyon.2023.e13672. eCollection 2023 Feb. Heliyon. 2023. PMID: 36852029 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical